Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PureOptic is a veterinary ophthalmic regenerative therapy from Hilltop Bio designed for equine and small animal eye conditions, formulated as easy-to-use eye drops with optimized viscosity to prolong contact time with the ocular surface.[10][11] It incorporates the same biologically active “regenerative cargo” used in Hilltop Bio’s other products— including cytokines, microRNA, growth factors, exosomes, and bioscaffold components—aimed at normalizing and supporting repair of damaged ocular tissues resulting from injury or disease.[10][11] The product is supplied for use by licensed veterinarians, with reconstitution and handling similar to Hilltop Bio’s other biologically derived formulations and requiring refrigerated storage after reconstitution.[7][10]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PureOptic.